IL108183A0 - Pharmaceutical compositions for transdermal hormone replacement therapy - Google Patents

Pharmaceutical compositions for transdermal hormone replacement therapy

Info

Publication number
IL108183A0
IL108183A0 IL10818393A IL10818393A IL108183A0 IL 108183 A0 IL108183 A0 IL 108183A0 IL 10818393 A IL10818393 A IL 10818393A IL 10818393 A IL10818393 A IL 10818393A IL 108183 A0 IL108183 A0 IL 108183A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
replacement therapy
hormone replacement
transdermal hormone
transdermal
Prior art date
Application number
IL10818393A
Other languages
English (en)
Original Assignee
Jencap Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jencap Research Ltd filed Critical Jencap Research Ltd
Publication of IL108183A0 publication Critical patent/IL108183A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL10818393A 1992-12-28 1993-12-27 Pharmaceutical compositions for transdermal hormone replacement therapy IL108183A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US99682092A 1992-12-28 1992-12-28

Publications (1)

Publication Number Publication Date
IL108183A0 true IL108183A0 (en) 1994-04-12

Family

ID=25543344

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10818393A IL108183A0 (en) 1992-12-28 1993-12-27 Pharmaceutical compositions for transdermal hormone replacement therapy

Country Status (8)

Country Link
EP (1) EP0675720A1 (fr)
CN (1) CN1097987A (fr)
CA (1) CA2152780A1 (fr)
IL (1) IL108183A0 (fr)
MX (1) MXPA94000108A (fr)
SI (1) SI9300687A (fr)
WO (1) WO1994014450A1 (fr)
ZA (1) ZA939686B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5855920A (en) * 1996-12-13 1999-01-05 Chein; Edmund Y. M. Total hormone replacement therapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
DE3888269T2 (de) * 1987-09-24 1994-07-07 Jencap Research Ltd Hormon-Zusammensetzung und -Anwendung.

Also Published As

Publication number Publication date
SI9300687A (en) 1994-09-30
WO1994014450A1 (fr) 1994-07-07
CA2152780A1 (fr) 1994-07-07
ZA939686B (en) 1994-08-29
EP0675720A1 (fr) 1995-10-11
MXPA94000108A (es) 2004-08-20
CN1097987A (zh) 1995-02-01

Similar Documents

Publication Publication Date Title
IL117728A0 (en) Pharmaceutical compositions for transdermal administration
IL92496A0 (en) Compositions for transdermal delivery of estradiol
GB2264235B (en) Composition for nasal treatment
GB9319500D0 (en) Pharmaceutical composition
GB9204354D0 (en) Compounds for medicinal use
AU2345695A (en) Pharmaceutical composition for transdermal delivery
GB2272375B (en) Pharmaceutical composition
EP0587047A3 (en) Gestagenes containing pharmaceutical composition
IL104409A0 (en) Pharmaceutical compositions containing pyridobenzodiazepinones for axial myopia therapy
IL108197A0 (en) Pharmaceutical composition for preventing or treating arterioscleriosis
GB9221707D0 (en) Pharmaceutical composition
IL108183A0 (en) Pharmaceutical compositions for transdermal hormone replacement therapy
ZA94155B (en) Pharmaceutical composition
ZA935078B (en) Pharmaceutical composition
IL93143A0 (en) Transdermal drug delivery composition
ZA89552B (en) Pharmaceutical composition for 4-aroylimidazol-2-ones
NZ268125A (en) Growth hormone pharmaceutical composition
ZA924061B (en) Pharmaceutical composition
ZA935931B (en) Pharmaceutical composition
ZA931984B (en) Pharmaceutical composition
IL95508A0 (en) Pharmaceutical compositions for transdermal administration
GB9206151D0 (en) Nasal pharmaceutical composition
GB9214591D0 (en) Therapeutic composition
IE871371L (en) Compositions for transdermal therapeutic systems of¹diuretics
EG20185A (en) Drug material suitable for micronisation